'Survival gene' stops strains of tuberculosis mutating into deadly 'superbugs'

January 27, 2017
This photomicrograph reveals Mycobacterium tuberculosis bacteria using acid-fast Ziehl-Neelsen stain; Magnified 1000 X. The acid-fast stains depend on the ability of mycobacteria to retain dye when treated with mineral acid or an acid-alcohol solution such as the Ziehl-Neelsen, or the Kinyoun stains that are carbolfuchsin methods specific for M. tuberculosis. Credit: public domain

Scientists have discovered a key 'survival gene' that prevents strains of tuberculosis (TB) from mutating into drug-resistant 'superbugs'.

In a joint study, published today, Friday January 27th 2017, in the journal Nature Communications, scientists from the Centro Nacional de Biotecnología in Madrid and the University of Sussex in Brighton, report the discovery of a gene called NucS that dramatically reduces mutation rates in mycobacteria—the infectious microbe which causes tuberculosis (TB).

TB, which is spread from person to person through the air, is one of the top 10 causes of death worldwide with 1.8 million people dying from the disease last year. Drug-resistant strains of TB have already been identified in 105 countries and the researchers involved in this study believe that the identification of a key gene, required to supress mutation rates in mycobacteria, is an important step towards understanding how 'superbugs' develop.

Using a genetic screen, which involved individually knocking out nearly every gene (11,000 ) in mycobacteria, and screening whether mutant strains grew on a specific antibiotic (rifampicin), the scientists discovered that a DNA repair enzyme, produced by the NucS gene, dramatically reduces mutations from occurring.

The researchers also discovered that genetic variations in the NucS gene significantly influence the mutation rates in clinically isolated strains of mycobacteria. More work needs to be done, but the scientists believe this discovery could also play a role in understanding the development of in patients already suffering from TB.

Professor Aidan Doherty, from the University of Sussex, said: "The rise of antibiotic resistance is a major threat to global health and, if we are to limit its impact on infectious diseases, we first need to identify the mechanisms that prevent bacteria from mutating in the first place. This knowledge will then enable us to better understand how pathogens develop into 'superbugs'.

"Incredibly, for many years it was believed that mycobacteria lacked any mutation avoidance genes. Therefore, the discovery that the NucS gene reduces the rate at which mutations occur in these pathogens is a crucial first step towards identifying the genetic factors that influence the onset of antibiotic-resistance. This will enable scientists and clinicians to screen for strains that are most likely to develop drug-resistance and figure out strategies to tackle this serious threat."

Professor Jesus Blázquez, from the Centro Nacional de Biotecnología, said: "Not only does this study identify that mutations can be reversed in mycobacteria, it reveals that the loss of this DNA repair process can cause a huge increase in the mutation rates, significantly increasing the likelihood of these pathogens acquiring mutations - which can cause antibiotic resistance.

"Now we know that that NucS dramatically reduces in —it is vital that we take advantage of this and work towards exploiting this discovery to help doctors and microbiologists to predict and prevent the development of antibiotic resistance during treatments."

The study published in Nature Communications is entitled, "A non-canonical mismatch repair pathway in prokaryotes".

Explore further: Research sheds light on mechanism that leads to drug-resistant superbugs

Related Stories

Research sheds light on mechanism that leads to drug-resistant superbugs

September 29, 2016
Drug-resistant organisms, or so-called "superbugs," are a growing public health threat because "last-resort" therapeutics-employed only when other drugs fail to kill an infection-are failing. A University of Georgia-led research ...

Drug resistance mutations also enhance growth in malaria parasite

November 10, 2016
Some mutations that enable drug resistance in the malaria-causing parasite Plasmodium falciparum may also help it grow, according to a new study published in PLOS Pathogens.

'Lonely' bacteria increase risk of antibiotic resistance

April 29, 2014
Scientists from The University of Manchester have discovered that 'lonely' microbes are more likely to mutate, resulting in higher rates of antibiotic resistance.

Scientists reveal how natural antibiotic kills tuberculosis bacterium

September 17, 2012
A natural product secreted by a soil bacterium shows promise as a new drug to treat tuberculosis report scientists in a new study published in EMBO Molecular Medicine. A team of scientists working in Switzerland has shown ...

Recommended for you

Scientists develop infection model for tickborne flaviviruses

August 22, 2017
National Institutes of Health (NIH) scientists have filled a research gap by developing a laboratory model to study ticks that transmit flaviviruses, such as Powassan virus. Powassan virus was implicated in the death of a ...

Zika virus stifles pregnant women's weakened immune system to harm baby, study finds

August 21, 2017
The Zika virus, linked to congenital birth defects and miscarriages, suppresses a pregnant woman's immune system, enabling the virus to spread and increasing the chances an unborn baby will be harmed, a Keck School of Medicine ...

Novel approach to track HIV infection

August 18, 2017
Northwestern Medicine scientists have developed a novel method of tracking HIV infection, allowing the behavior of individual virions—infectious particles—to be connected to infectivity.

Faulty gene linked to obesity in adults

August 18, 2017
Groundbreaking new research linking obesity and metabolic dysfunction to a problem in the energy generators in cells has been published by researchers from the Harry Perkins Institute of Medical Research and The University ...

Two lung diseases killed 3.6 million in 2015: study

August 17, 2017
The two most common chronic lung diseases claimed 3.6 million lives worldwide in 2015, according to a tally published Thursday in The Lancet Respiratory Medicine.

New test differentiates between Lyme disease, similar illness

August 16, 2017
Lyme disease is the most commonly reported vector-borne illness in the United States. But it can be confused with similar conditions, including Southern Tick-Associated Rash Illness. A team of researchers led by Colorado ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

katesisco
1 / 5 (1) Jan 28, 2017
Could this be behind the reason leprosy now infects an estimated 5% with non mutated leprosy? And the reason HIV resistance exists in leprosy infected Europe?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.